Preclinical Animal Telemetry Market 2024-2028, Poised for Growth Amid Rising Demand in Drug Development
The Global preclinical animal telemetry market is projected to grow by USD 21.55 million between 2024 and 2028, registering a CAGR of 5.69%. This growth is driven by the increasing demand for drug discovery, safety testing, and regulatory compliance across pharmaceutical and biotechnology industries

For more details about the industry, get the PDF sample report for free
Market Segmentation
By End-User
- Industrial Laboratories and CROs (Largest segment)
- Academic Government and Other Research Laboratories
By Type
- Small Animal Telemetry (Includes mice, rabbits, ferrets, rats, hamsters, and guinea pigs)
- Large Animal Telemetry
Regional Market Trends
- North America
- Europe
- Asia
- Rest of World (ROW)
Key Market Drivers
- Growth in preclinical research & testing
- Rising prevalence of cardiovascular diseases, metabolic disorders, cancer, and diabetes
- Demand for real-time, automated physiological monitoring
Significant Market Trends
- Development of SEND-compatible software (U.S. FDA-mandated Standard of Exchange of Nonclinical Data)
- Advancements in wireless, miniaturized telemetry implants
Challenges Impacting Growth
- Limited battery life of telemetry implants
- Design scalability issues
- Compatibility constraints with existing lab systems
Get more details by ordering the complete report
Key Companies in the Preclinical Animal Telemetry Market
Some of the key companies of the Preclinical Animal Telemetry Market are as follows:
- ADInstruments Pty Ltd.
- Advanced Telemetry Systems Inc.
- BIO RESEARCH CENTER Co. Ltd.
- BIOPAC Systems Inc.
- Cambridge NeuroTech
- Charles River Laboratories International Inc.
- Ecotone Goc
- emka TECHNOLOGIES
- ETISENSE SAS
- Harvard Bioscience Inc.
- Indus Instruments
- Instem Plc
- Kent Scientific Corp.
- Muromachi Kikai Co. Ltd.
- Somark Innovations
- Star Oddi hf
- Starr Life Sciences Corp.
- Telemetry Solutions Inc.
- TSE Systems GmbH
- Vivonics Preclinical Ltd.